Business Context and Reporting Period
This Form 8-K was filed by Sonim Technologies, Inc. (not DNA X, Inc.) on September 29, 2025. The filing reports the entry into a Material Definitive Agreement regarding a committed equity facility.
Key Financial Metrics and Transaction Details
The filing details a "ChEF" (Chardan Equity Facility) purchase agreement with Chardan Capital Markets LLC. Key terms include:
- Facility Size: Up to $500,000,000 in aggregate gross purchase price of newly issued common stock.
- Discount: Shares are sold at a fixed 3.5% discount to the Volume Weighted Average Price (VWAP).
- Exchange Cap: Issuance is limited to 19.99% of outstanding shares (2,066,747 shares) unless the average sale price meets or exceeds the Nasdaq Minimum Price of $0.6277 per share.
- Beneficial Ownership Limitation: Chardan cannot beneficially own more than 4.99% of outstanding shares.
- Term: The agreement lasts for 36 months from the Effective Date or until the $500 million cap is reached.
- Legal Fees: The Company will reimburse Chardan up to $125,000 for initial legal fees and up to $25,000 per fiscal quarter for ongoing due diligence.
Material Changes and Use of Proceeds
The filing does not report changes to historical revenue, profit, or cash flow. The primary material change is the establishment of the equity facility. The Company has specified the following use of proceeds:
- Debt Repayment: A minimum of 33% of proceeds will be used to pre-pay a promissory note of $2,755,000 issued to Streeterville Capital, LLC on July 11, 2025.
- General Corporate Purposes: Remaining proceeds will be used for operations, working capital, and business strategy.
Guidance, Risks, and Contingencies
Management Commentary: The Company retains sole discretion on the timing and amount of sales, with no obligation to sell any securities. The facility is structured similarly to an "at-the-market" offering.
Risks and Contingencies:
- Dilution: Issuance of new shares will dilute existing shareholders, subject to the Exchange Cap and Beneficial Ownership Limitation.
- Market Conditions: Sales depend on market conditions and the trading price of the Common Stock.
- Termination: The agreement may terminate early if the stock is delisted, bankruptcy proceedings commence, or if either party provides 10 trading days' notice (subject to conditions for Chardan).
- Short Sales: Chardan confirmed no short sales or hedging transactions were in effect as of the agreement date.
Important Facts for Investor Verification
- Verify the current trading price of SONM relative to the $0.6277 Nasdaq Minimum Price to determine if the 19.99% Exchange Cap applies.
- Confirm the status of the $2,755,000 promissory note to Streeterville Capital, LLC.
- Monitor future filings for the "Effective Date" of the Initial Resale Registration Statement, which triggers the ability to sell shares.
- Review the impact of the 3.5% discount on the Company's capital raising efficiency compared to market prices.
- Check for any subsequent sales notices or updates on the amount of shares sold under the facility.